Cybin ($CYBN) Exploring Psilocybin & DMT for Mental Wellness

Cybin is presenting data from its first-in-human trials of its proprietary psilocybin and DMT molecules for the treatment of depression and anxiety disorders during a virtual R&D day webcast on February 28th.